These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 16533766
1. PIK3CA mutations in head and neck squamous cell carcinoma. Qiu W, Schönleben F, Li X, Ho DJ, Close LG, Manolidis S, Bennett BP, Su GH. Clin Cancer Res; 2006 Mar 01; 12(5):1441-6. PubMed ID: 16533766 [Abstract] [Full Text] [Related]
2. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma. Al-Amri AM, Vatte C, Cyrus C, Chathoth S, Hashim TM, Mohamed YS, Al Ali R, Alsaid A, Al Ali A. Cancer Biomark; 2016 Mar 01; 16(3):377-83. PubMed ID: 26889984 [Abstract] [Full Text] [Related]
3. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas. Murugan AK, Hong NT, Fukui Y, Munirajan AK, Tsuchida N. Int J Oncol; 2008 Jan 01; 32(1):101-11. PubMed ID: 18097548 [Abstract] [Full Text] [Related]
4. PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas. Schönleben F, Qiu W, Ciau NT, Ho DJ, Li X, Allendorf JD, Remotti HE, Su GH. Clin Cancer Res; 2006 Jun 15; 12(12):3851-5. PubMed ID: 16778113 [Abstract] [Full Text] [Related]
5. Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies. Wirtz ED, Hoshino D, Maldonado AT, Tyson DR, Weaver AM. JAMA Otolaryngol Head Neck Surg; 2015 Jun 15; 141(6):543-9. PubMed ID: 25855885 [Abstract] [Full Text] [Related]
9. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma. Fenic I, Steger K, Gruber C, Arens C, Woenckhaus J. Oncol Rep; 2007 Jul 15; 18(1):253-9. PubMed ID: 17549376 [Abstract] [Full Text] [Related]
11. Genetic alterations of the PIK3CA oncogene in human oral squamous cell carcinoma in an Indian population. Shah S, Shah S, Padh H, Kalia K. Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov 15; 120(5):628-35. PubMed ID: 26453385 [Abstract] [Full Text] [Related]
14. Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer. Nichols AC, Black M, Yoo J, Pinto N, Fernandes A, Haibe-Kains B, Boutros PC, Barrett JW. BMC Pharmacol Toxicol; 2014 Nov 27; 15():66. PubMed ID: 25428177 [Abstract] [Full Text] [Related]
17. Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population. Kostakis GC, Papadogeorgakis N, Koumaki V, Kamakari S, Koumaki D, Alexandridis C. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May 27; 109(5):e53-8. PubMed ID: 20416519 [Abstract] [Full Text] [Related]